Clinical trial
Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age)…
NCT00317187 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00317187 |
|---|---|
| Title | Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. |
| Official title | Partially Blinded Study to Assess Reactogenicity & Safety of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ in Healthy Infants After a Hepatitis B Birth Dose |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Diphtheria, Whole Cell Pertussis, Tetanus, Haemophilus Influenzae Type b |
| Intervention type | Biological |
| Interventions | Tritanrix-HepB/Meningitec conjugate vaccine, Tritanrix/Hiberix vaccine |
| Enrollment | 500 |
| Start date | Jun 8, 2004 |
| Primary completion | Jan 16, 2005 |
| Completion | Jan 16, 2005 |
| First posted | Apr 24, 2006 |
| Last update posted | Aug 15, 2018 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: